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Hormonendria in basic physiological processes has rendered this organelle a receiver and
integrator of multiple regulatory signals. Steroid and thyroid hormones are major modulators of
mitochondrial functions and the question arises as to how these molecules act at the molecular level. The
detection in mitochondria of steroid and thyroid hormone receptors suggested their direct action on
mitochondrial functions within the context of the organelle. The interaction of the receptors with regulatory
elements of the mitochondrial genome and the activation of gene transcription underlies the hormonal
stimulation of energy yield. Glucocorticoid activation of hepatocyte RNA synthesis is one of the experimental
models exploited in this respect. Furthermore, the interaction of the receptors with apoptotic/antiapoptotic
factors is possibly associated with the survival-death effects of the hormones. In addition to the steroid/
thyroid hormone receptors, several other receptors belonging to the superfamily of nuclear receptors, as well
as transcription factors with well deﬁned nuclear actions, have been found in mitochondria. How these
molecules act and interact and how they can affect the broad spectrum of mitochondrial functions is an
emerging exciting ﬁeld.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria are the powerhouses of the cell, generating over 90%
of its energy requirements by way of oxidative phosphorylation in the
respiratory chain. The mitochondria host several other important
metabolic processes, e.g. the Krebs cycle, β-oxidation of fatty acids and
heme biosynthesis, thus playing a central role in cellular events [1,2].
Furthermore, they are involved in oxidative stress by way of reactive
oxygen species generation, in immunomodulation and in ageing [3–
6]. Consequently, these unique organelles are rendered receivers and
integrators of several regulatory signals, modulating metabolic,
growth, developmental and apoptotic processes [3,7–10].
Steroid and thyroid hormones are major regulators of such
processes and their multiple actions on mitochondria in this respect
have been explored [11–16]. Well studied are the effects of these
hormones on biogenesis of mitochondria in muscle, distal colon,
kidney and liver [15–17], as well as the actions of glucocorticoids and
estrogens on apoptosis and survival of various cells, such as
lymphocytes and endothelia [18–21]. As regards biogenesis of
mitochondria and the respiratory complexes, a central feature of the
hormonal regulation of this process is the encoding of the subunits of+30 210 7273677.
ll rights reserved.the respiratory enzymes in two cell compartments, nuclei and
mitochondria [22], necessitating the coordination of the hormonal
induced gene activation in two different cell sites [23–28]. The
presence of steroid and thyroid hormone receptors in mitochondria
(Table 1) [29,30] implicated a direct action of the hormones by way of
their cognate receptors on mitochondrial gene transcription [31–33],
which, in the case of thyroid hormones, has been experimentally
veriﬁed [34,35].
2. Action of glucocorticoids on RNA metabolism of hepatocytes
Glucocorticoids are major gluconeogenic agents, inducing liver
enzymes involved in this process by way of cognate receptor
activation of gene transcription [36]. Hormone administration to
adrenalectomized rats markedly stimulates nuclear RNA synthesis,
encompassing HnRNA containing the mRNAs of the induced enzymes,
ribosomal RNA and tRNA [37–39]. Importantly, mitochondrial RNA
synthesis is also activated by the hormones [37,40]. This intense
nucleic acid stimulation requires a high expenditure of energy, which
the cell must eventually replenish. The involvement of mitochondrial
RNA synthesis in the hormonal response can be correlated to this
energy regeneration process, as the sole functional role of the
mitochondrial genome is to encode subunits of enzymes of oxidative
phosphorylation (OXPHOS) and the RNAs participating in the protein
syntheticmachinery of themitochondrion. Due to the fact thatmost of
Table 1
Receptors of the superfamily of nuclear receptors found in mitochondria
Receptor Cell type
Glucocorticoid Rat liver
HeLa, Hep-2, HepG2, SaOS-2
Rat brain, C6-glioma
Salamander Müller
Thymic epithelial
Estrogen beta HepG2, SaOS-2, MCF-7
Rabbit ovarian, uteri
Murine hippocampal
Neurons
Human lens epithelial
Human spermatocytes
Murine cardiomyocytes
Endothelial
Androgen Human spermatocytes, LNCaP
Thyroid Rat liver, cardiac
RXR Rat liver
RAR Rat liver
Nur77/TR3 Gastric cancer cell lines
T cells, LNCaP
PPARgamma2 Rat Liver
Reviewed in [14,29,30].
Fig. 2. Detection of a phosphorylated form of GR in mitochondrial extracts of HepG2
cells. Soluble cytosol (SC), mitochondrial membranous fraction (Msed) and mitochon-
drial soluble fraction (Msol) of HepG2 cells were isolated applying differential
centrifugation and discontinuous sucrose gradient, as previously described [18]. Equal
amounts of protein extracts from these fractions were submitted to electrophoresis and
transferred to nitrocellulose membrane. Detection of the glucocorticoid receptor
(A) and its phosphorylated form in Ser 211 (B) was achieved using speciﬁc antibodies
recognizing the human GR and the phosphorylated glucocorticoid receptor (Ser 211)
(provided by SantaCruz and cell signaling (# 4161), respectively).
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formation of active respiratory complexes, a hormonal coordination of
nuclear and mitochondrial transcription is necessary. This coordina-
tion is realized by way of activation of nuclearly encoded mitochon-
drial transcription factors, whose subsequent increased presence in
mitochondria can per se stimulate the organelles transcription
machinery [23–25,28,41]. In addition, a direct action of glucocorti-
coids on mitochondrial transcription was suggested (Fig. 1). This wasFig. 1. Nuclear and mitochondrial action of steroid/thyroid hormones on OXPHOS
biosynthesis by way of cognate receptors. In the nucleus, the hormone–receptor
complex induces OXPHOS genes, and genes of mitochondrial transcription factors
[13,14,29,30]. The mitochondrial transcription factors, subsequently, activate mitochon-
drial gene transcription. In addition, the hormone, can directly affect transcription of
the mitochondrial OXPHOS genes by way of cognate mitochondrial receptors and their
interaction with respective binding sites on the mitochondrial genome.based on studies of hormone distribution in liver cells, demonstrating
a very rapid uptake of 3H-cortisol in mitochondria, with a similar
kinetics as the uptake of the hormone in nuclei [42]. Furthermore,
analysis of the radioactivity recovered from the liver cells revealed the
bulk of the radioactivity in the cytosol, in form of metabolites, as the
liver is not only a site of action of glucocorticoids but also of their
metabolic transformation. However, the radioactivity recovered in the
nuclear and mitochondrial fractions was mostly non-metabolized
cortisol [42], suggesting that the mitochondrion, similarly to the
nucleus, could be a direct site of action of glucocorticoids byway of the
cognate receptor. Indeed, the glucocorticoid receptor (GR) was
detected in liver mitochondria of adrenalectomized rats after
hormonal induction of the animals, translocating from the cytoplasm
[43]. Subsequently, the glucocorticoid receptor was detected in
various other cell types [14,29,30] (Table 1). In our efforts to
characterize the mitochondrial GR (mtGR) by Western blot analysis,
we detected a 90 kDa GR isoform [18] which could correspond to the
GRαB or GRαC isoform of the receptor [44]. This isoform, as it is
previously suggested [45], may also represent a functional proteolytic
product of an inducible cytosolic endoprotease activation, which leads
to uncovering cryptic mitochondrial targeting signals and to mito-
chondrial translocation of the product [45]. Lower molecular weight
GR fragments, predominantly found in liver mitochondria, could
correspond to other GRα isoforms or represent proteolytic fragments
of the receptor. The mitochondrial GR is present in a phosphorylated
form (Fig. 2). These ﬁndings supported the suggestion, that the
receptor could have direct effects on mitochondrial transcription,
similarly as its action on nuclear genes.
3. Effects and molecular mechanisms of glucocorticoid action on
RNA synthesis of hepatocyte mitochondria
Analysis ofmitochondrial DNA of humans and rodents revealed the
presence of nucleotide sequences with high similarity to glucocorti-
coid responsive elements (GREs) within the regulatory sites (D-loop)
of the genome [46] (Fig. 3). In addition, potential GREs were also
found within structural genes, e.g. of cytochrome oxidase I, ND I and
12S RNA [46]. Some of these sequences were shown to interact with
the glucocorticoid receptor, as demonstrated in gel shift assays [49],
and were able to confer hormone inducibility to reporter genes in
transfection assays [50]. ChIP analysis of isolated mitochondria from
hepatocarcinoma HepG2 cells veriﬁed binding sites for the glucocor-
ticoid receptor in the D-loop of themitochondria and in the genes ND I
and 12S RNA (Psarra A-M.G., in preparation), supporting a direct
action of the receptor on mitochondrial transcription.
If the coordination of mitochondrial transcription by glucocorti-
coids is solely accomplished indirectly by way of nuclear gene
activation of mitochondrial transcription factors, then inhibition of
nuclear RNA synthesis would block the activation of mitochondrial
Fig. 3. The mammalian mitochondrial genome [47] and sites showing sequence
similarity to hormone responsive elements (HREs) for steroid and thyroid hormones.
The mammalian mitochondrial genome is a circular double stranded molecule of
approximately 16 kb (human: 16,569 bases) composed of a heavy (H) and a light
(L) strand. The L strand is transcribed from one predominant promoter (PL), whereas
the H strand is transcribed from two adjacent promoters (PH1 and PH2), located in the
control region, which includes a displacement (D) loop. Transcription emanating from
PH2 and PL generates long, polycistronic products, subsequently processed at the sites
of transfer RNA coding genes, liberating mature mRNAs and t-RNAs. Transcription from
PH1 produces a short message containing the two rRNAs, terminating at a speciﬁc site
on the tRNA-Leu gene. A transcription terminating factor (mTERF) promotes the
termination of transcription initiated at the PH1 site. The mRNAs encode three subunits
of cytochrome oxidase (I, II and III, COX I, COX II, COX III), seven of NADH-CoQ-reductase
(ND I–VI and ND4L), one of cytochrome b (Cyt-b), two of ATP-synthase (ATP 6, 8), two
ribosomal RNAs (12S and 16S rRNA) and 22 tRNAs. Only NDVI and the Gln, Ala, Asn, Cys,
Tyr, Ser, Glu and Pro-tRNAs are generated from the light strand transcript. Three
transcription factors have been characterized, mTFA, mTFB1 and mTFB2. The sites on
the genome of the predicted [32,46] and experimentally veriﬁed [33, 48–51] binding
sites for steroid and thyroid hormones are depicted: Open arrows: HREs for class I
receptors, ﬁlled arrows: HREs for class II receptors [from Psarra and Sekeris [14]].
Fig. 4. EffectofmtGRonmitochondrial RNA synthesis in thepresenceofα-amanitin inHEK
293 cells. HEK 293 cells, grown in DMEM supplemented with 10% FBS, 2 mM L-glutamine
and penicillin/streptamycin on 6 well plates, were transiently transfected with a pIRES
vector carrying a mitochondria targeted GR. Cells were treatedwith 10 μg/mlα-amanitin,
for 5 h, at 37 °C.α-Amanitin treatedaswell asnon treatedcellswas further incubated in the
presence of 10−6 DEX, for 1 h. Subsequently, cells were washed with phosphate buffer
saline and total RNA was extracted using Trizol, followed by DNase treatment (Promega)
and reverse transcription into cDNA, using random primers and superscript II reverse
transcriptase (Invitrogen). Expressed levels of mRNA were quantitated using real-time
RCR, which was performed after mixing the cDNA with SYBR GreenER qPCR super mix
Universal (Invitrogen) and appropriate primers. Products were quantitated with a
Chromo4 Real-Time System (Bio-Rad). Conditions for PCR were: 52 °C for 2 min, 95 °C
for 2min, 35 cycles of 95 °C for 15 s and 60 °C for 40 s, followedby 60 °C for 10min. Primers
for cytochrome oxidase subunits I–IV (COX I, COX II, COX III, COX IV), cytochrome b (Cyt b),
NADHdehydrogenase subunits I, II, (ND I,ND II),12S and16S ribosomal RNA (12S,16S), and
ATP synthase subunit 8 (ATP 8), glyceraldehyde 3-phosphate dehydrogenase (GAPDH,
reference gene), were: COX I forward: ccctagaccaaacctacgccaaa; COX I reverse:
aggccgagaaagtgttgtgggaa; COX II forward: acagatgcaattcccggacgtcta; COXII reverse:
ggcatgaaactgtggtttgctcca; COX III forward: tcacttccactccataacgctcct; COX III reverse:
gtgttacatcgcgccatcattggt; Cyt b forward: agtcccaccctcacacgattcttt; Cyt b reverse: agtaagcc-
gagggcgtctttgatt; ND I forward: atggccaacctcctactcctcatt; ND I reverse: ttatggcgtcagc-
gaagggttgta; ND II forward: ccatctttgcaggcacactcatca; ND II reverse:
attatggatgcggttgcttgcgtg; 12S forward: aaactgctcgccagaacactacga; 12S reverse: tgagcaa-
gaggtggtgaggttgat; 16S forward: taccctcactgtcaacccaacaca; 16S reverse: ttaaacatgtgt-
cactgggcaggc; ATP 8 forward: accgtatggcccaccataattacc; ATP 8 reverse:
tttatgggctttggtgagggaggt; COX IV forward: agaaagtcgagttgtatcgcatt; COX IV reverse:
gataacgagcgcggtgaaac; GAPDH forward: catgagaagtatgacaacagcct; GAPDH reverse:
agtcctttccacgataccaaagt.
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stimulating mitochondrial transcription, RNA synthesis in mitochon-
dria would continue to proceed, perhaps somewhat attenuated, even
in the presence of inhibitors of nuclear RNA synthesis. To this end,
experiments with α-amanitin, a direct inhibitor of Pol II [52,53] and
indirectly, of Pol I mediated transcription [54], were performed.
Indeed, various cell lines, e.g. HEK 293, HepG2 and HeLa cells,
transfected with a construct carrying a mitochondrial targeted GR
gene, reacted to the addition of an inducing dose of glucocorticoids by
increased transcription of mitochondrial genes, among them ND I, ND
II, ATP 8, Cyt b, COX I, COX II, COX III, 12S and 16S RNA, even in the
presence of α-amanitin, whereas the induction of the nuclearly
encoded COX IV gene was inhibited by the amatoxin (Fig. 4).
To provide further support for the direct activation by glucocorti-
coids of mitochondrial transcription, experiments are under way to
study the import mechanism of the receptor and the consequence of
this translocation for mitochondrial functions, in an in organello
mitochondrial system derived from rat liver cells [55].
4. Other nuclear transcription factors in mitochondria
The detection of receptors for steroid and thyroid hormones in
mitochondria (Table 1) initiated research towards elucidating their
function within the conﬁnes of this organelle. As regards the thyroid
hormone receptor, Enriquez et al. [34] and Casas et al. [35] have
demonstrated a direct effect of the cognate receptor on mitochondrial
transcription. A series of publications have strongly supported similareffects of the estrogen receptors on mitochondrial transcription of
several target tissues [20,21,56]. Furthermore, apoptotic and anti-
apoptotic actions of mitochondrial glucocorticoid and estrogen
receptors, respectively, have been reported [14,19–21,57–60].
In previous publications and in the work presented here, a
stimulatory action of glucocorticoids on mitochondrial transcription
has been shown [37,40]. These ﬁndings support the concept whereby
coordination of OXPHOS biosynthesis by steroid and thyroid
hormones can be achieved by the direct effects of their cognate
nuclear and mitochondrially localized receptors on nuclear and
Table 2
Nuclear transcription factors found in mitochondria
Receptor Cell type
NF-κB Jurkat T cells
Human ﬁbroblast HT1080
Prostatic carcinoma cell lines
U937 leukemic
HeLa
AP-1 Murine brain
Murine hippocampal
CREB Brain neurons, dentral granular
p53 Human skin ﬁbroblasts
Rat embryo ﬁbroblasts
HA-1 hamster ﬁbroblasts
Human HT1080
Thymocytes
MRC-5, 32D, BAF-3
Human ML-1, MCF-7
Mouse liver
KB human epidermoid
Reviewed in [14,30,61].
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addition to the well established mechanism of coordination through
hormonal activation of nuclearly encoded mitochondrial transcription
factors [16,23,24,26–28,30,61–63].
The central role of mitochondria in several basic functions
necessitates coordinationwith the functions of other involved cellular
organelles by a variety of regulatory molecules. One such category is
the superfamily of nuclear receptors, many of which have been
localized in mitochondria from various sources [30]. Recently, the
catalogue of regulatory molecules found in mitochondria has been
enriched [14,64,65] (Table 2). Many of these molecules represent
transcription factors with important role in nuclear gene regulation
and their role in mitochondrial functions is now beginning to be
revealed, particularly as regards cell survival and apoptosis [14,64,65].
Some of these factors seem to act on mitochondrial gene expression,
others in a non-genomic manner, interacting directly with other
regulatory molecules.
AP-1, NF-κB, CREB and p53 are among the major nuclear
transcription factors detected in mitochondria of various cell types.
AP-1 has been found in mitochondria of rat cerebral cortex and dental
granular cells [66,67] and in mitochondria of prostate LNCaP cancer
cells [68]. Binding of this factor to mitochondrial DNA, in the
regulatory (D-loop) region, has been shown and associated with the
regulation of mitochondrial DNA transcription [67]. Similarly, NF-κB
has been localized in mitochondria of human leukemic Jurkat [69,70],
ﬁbroblast and prostate cancer [68,71] cell lines, whereas CREB has
been found in brain mitochondria [72–74]. ChIP analysis identiﬁed
CREB binding to cognate responsive elements in the D-loop. The
antioxidant dexerozamine, which inhibits stress induced death,
increased DNA-binding of CREB suggesting that modulation of
mitochondrial transcription could underlie the salutary effect of
dexerozamine. Several publications demonstrate the presence of p53
inmitochondria of many cell types [75–93]. Themajority of the results
point to an apoptotic action of p53 by way of a non-genomic
mechanism and interaction with apoptotic factors [77,79,81,88,89].
Thus, targeting of p53 to mitochondria of p53-null SaOS-2 osteosar-
coma cells is sufﬁcient to induce apoptosis, furthermore the
transactivation region of p53 is not needed for this effect [77,81].
However, some publications suggest a parallel genomic role of p53 in
mitochondria [78,82–85].
5. Perspectives
The wealth of information amassed concerning the presence in
mitochondria of regulatory molecules regarded as solely involved in
nuclear actions increases the regulatory potential of mitochondria andopens perspectives in deepening our knowledge on the physiology of
mitochondria and on recognizing and understanding the complexity
of this organelle's interaction with the other cell compartments. An
intriguing facet of this research is the mode of interaction of
eukaryotic regulatory factors with the prokaryotic transcriptosome
and with bona ﬁde mitochondrial components. The new knowledge
will be instrumental in delineating the aetiopathology of mitochon-
dria related diseases and in designing therapeutic strategies.
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